Ming-chuan Hsu

No. 367, Shengli Road, 704
Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

KMT2C mutations in breast cancer: molecular mechanisms of cancer promotion, clinical significance, and potential as biomarkers.

KMT2C mutations in breast cancer: molecular mechanisms of cancer promotion, clinical significance, and potential as biomarkers.

Journal: Critical reviews in oncology/hematology

Published: September 23, 2025

Early identification of high-risk older two-wheeler riders: A dual-sample approach for 30-day mortality prediction.

Early identification of high-risk older two-wheeler riders: A dual-sample approach for 30-day mortality prediction.

Journal: Accident; analysis and prevention

Published: June 11, 2025

Editorial: Breakthroughs in tumor stem cell research.

Editorial: Breakthroughs in tumor stem cell research.

Journal: Frontiers in cell and developmental biology

Published: September 08, 2024

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication.

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication.

Journal: Journal of clinical medicine

Published: May 30, 2019

Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.

Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.

Journal: Journal of hematology & oncology

Published: April 08, 2019

Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.

Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.

Journal: Cells

Published: February 26, 2019

Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression.

Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression.

Journal: Cancers

Published: October 26, 2018

Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling.

Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling.

Journal: Molecular cancer

Published: October 11, 2017

Orchestration of H3K27 methylation: mechanisms and therapeutic implication.

Orchestration of H3K27 methylation: mechanisms and therapeutic implication.

Journal: Cellular and molecular life sciences : CMLS

Published: February 21, 2017

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.

Journal: Oncotarget

Published: February 25, 2016

G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.

G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.

Journal: Scientific reports

Published: July 10, 2015

The ZNF304-integrin axis protects against anoikis in cancer.

The ZNF304-integrin axis protects against anoikis in cancer.

Journal: Nature communications

Published: February 02, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026